Transcriptomic Profiling of Peripheral Immune Cells in a Trial of Ruxolitinib with Nivolumab for Anti-PD1 Non-Responsive cHL
Consent Codes
GRUFocus / Diseases
Hodgkin DiseaseStudy Design
Case SetData Types
RNA-SeqSubjects
19Consent Codes
GRUFocus / Diseases
Hodgkin DiseaseStudy Design
Case SetData Types
RNA-SeqSubjects
19